This message was sent to ##Email##
|
|
|
|
|
Medical News Today
It may be feasible to treat pancreatic cancer by using one drug to get the cancer cells to depend on a single source of energy, and another drug to take it away from them.
The approach looks promising after a recent study successfully tested it on pancreatic cancer cells and mice in the laboratory.
READ MORE
Rush University Medical Center via Infection Control Today
Each year, approximately 5 million patients in the U.S. receive treatment that includes the insertion of a medical device such as a catheter, which puts them at increased risk of potentially life-threatening infection. Researchers have found a strategy that greatly reduced both overall infection and infection with antibiotic-resistant bacteria in a group of these patients.
READ MORE
|
Promoted by
|
|
|
|
 |
Outbreak News Today
In a follow-up on the measles situation in Texas, the Texas Department of State Health Services is now reporting 10 measles cases in the state in 2019.
This is more than the total reported in all of 2018. Texas reported nine cases of measles in 2018 and one in 2017.
READ MORE
Medical Xpress
An antibody taken from an Ebola survivor has been found to target all three human strains of the virus and could eventually lead to an all-purpose vaccine against the killer disease, scientists recently said.
Ebola, which can be lethal in 90 percent of cases if untreated, killed more than 11,000 people in 2014-15 in West Africa in what was the worst-ever outbreak of the hemorrhagic disease.
READ MORE
|
|
By Lynn Hetzler
 Influenza vaccines save lives over the years and prevent millions of additional people from getting sick from the flu. The CDC reported on Feb. 15 that the overall estimated effectiveness of the seasonal influenza vaccine was 47 percent, which means the vaccine cuts the risk of the flu by nearly half. One of the main problems with low effectiveness is that current vaccines do not cover all influenza strains, and strains mutate quickly, so people must undergo vaccinations each year to cover strains not included in previous vaccines. The results of a new study published in the journal Nature Immunology may change all that — researchers have identified an immune cell that can protect the body from all types of influenza.
READ MORE
 |
|
Prepare for leadership in a fast-growing field with the M.S. in Medical Laboratory Science at the University of Vermont, a Public Ivy and top 100 research university where close faculty-student mentorship enables the study of medical laboratory science emphasizing research, teaching, and advanced clinical practice.
|
|
Forbes
A second patient appears to have been “cured” of HIV following a stem cell transplant procedure, which replaces unhealthy, infected cells, with healthy blood cell precursors. The first successful stem cell transplant occurred in the “Berlin patient,” Timothy Ray Brown, in 2008 and, 10 years later, he is still free of HIV.
READ MORE
|
|
The min iSED™ is the newest addition to the iSED™ family of ESR analyzers from ALCOR Scientific. The min iSED™ is a single position, fully automated ESR analyzer that works directly from the primary EDTA tube and produces an ESR result in just 15 seconds. The min iSED™ is the ideal ESR analyzer for small laboratories, POL’s and emergency clinics.
Learn more
|
|
|
|
|
FlowSight - Flow Cytometry with Vision
|
The FlowSight offers high performance in a small package. Its design increases signal and minimizes noise to provide unmatched fluorescence sensitivity. Twelve detection channels simultaneously produce brightfield, darkfield and up to ten channels of fluorescence imagery of every cell.
Read more
|
|
|
|
|
Aston University via Phys.org
Scientists at Aston University have discovered a technique similar to medieval stained glass-making that can completely eradicate the deadliest hospital infections within hours.
Using a so-called bioactive phosphate glass containing small amounts of the metallic element cobalt, the researchers were able to achieve a "complete kill" of the deadly bacterial infections E.coli and candida albicans (a fungal infection associated with surgery), as well as a near-complete kill of staphylococcus aureus (the drug-resistant form of which is MRSA).
READ MORE
American Medical Technologists
Recommend training for non-lab staff through the Certificate in Point-of-Care Testing. From AMT, specialists in laboratory competencies.
READ MORE
American Chemical Society via Lab Manager
Malignant melanoma can be a particularly dangerous form of cancer, and more therapeutic options are needed. Now, researchers report in ACS Medicinal Chemistry Letters that a bacteria from seawater has inspired promising leads for an entirely new way to treat the disease.
READ MORE
|
|
DARK Daily
Recently, the federal Food and Drug Administration approved a smartphone-based at-home urine test that enables patients with chronic diseases, urinary tract infections or high-risk pregnancies to monitor their health using a testing method that’s as easy as taking a smartphone selfie. This latest breakthrough is another example of how technology is making it possible to move clinical laboratory testing closer to patients — in this instance into their homes. But it’s also taking away some of the urine testing being performed by medical laboratories.
READ MORE
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, contact Andy Keith at 972-402-7707.
MORE
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests. Learn more
|
|
|
|
Imperial College London via ScienceDaily
New cases of hepatitis C amongst HIV-positive men in London have fallen by nearly 70 percent in recent years. The new analysis of data from three clinics in London found 256 men were diagnosed between 2013-2018. New infections peaked at 17 for every 1,000 people studied in 2015 and fell to six by 2018.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
